Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2016Hepatology Medicine and PolicyOpen Access

Innovative sources for funding of viral hepatitis prevention and treatment in low- and middle-income countries: a roundtable meeting report

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDavid W. FitzsimonsUniversity of AntwerpGHGreet HendrickxUniversity of AntwerpJHJohannes F. HallauerDietrich Bonhoeffer Klinikum

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Fitzsimons et al. (2016) studied this question.

synapsesocial.com/papers/6a6f25f7febe604dd70828c6https://doi.org/10.1186/s41124-016-0022-8
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Hepatitis C in the United States2013 · 324 citations
  2. 2Charting the evolution of approaches employed by the Global Alliance for Vaccines and Immunizations (GAVI) to address inequities in access to immunization: a systematic qualitative review of GAVI policies, strategies and resource allocation mechanisms through an equity lens (1999–2014)2015 · 45 citations
  3. 3The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment2016 · 283 citations
  4. 4Hepatitis C Virus Reinfection Following Treatment Among People Who Use Drugs2013 · 96 citations